MedPath

Combined Pulsed Dye Laser and Topical Ranibizumab for Treatment of Port Wine Stain Birthmarks

Phase 1
Withdrawn
Conditions
Port-Wine Stain
Interventions
Device: Pulsed Dye Laser
Registration Number
NCT00667472
Lead Sponsor
University of California, Irvine
Brief Summary

The purpose of this study is to improve port wine stain therapeutic outcome in response to laser therapy. The researcher want to determine whether the combined use of pulsed dye laser therapy and topical ranibizumab will improve port wine stain therapeutic outcome.

Detailed Description

Combined use of pulsed dye laser to induce port wine stain blood vessel injury, and ranibizumab to prevent port wine stain blood vessel angiogenesis and recanalization after laser therapy, will improve port wine stain lesion blanching.

After pulsed dye laser treatment of the entire port wine stain, topical ranibizumab will be applied to two of the test sites for two weeks following pulsed dye laser therapy. The degree of port wine stain blanching which will be quantified objectively using visible reflectance spectroscopy measurements. port wine stain test site blanching responses following the combined use of pulsed dye laser and topical ranibizumab will be compared with pulsed dye laser only and with the baseline controls.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Port Wine Stain suitable for comparison testing
  • Age > 18 years of age
Exclusion Criteria
  • History of photodermatoses or skin cancer
  • use of known photosensitizing drugs
  • use of immunosuppressive drugs or systemic steroids
  • Pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Pulsed Dye LaserPulsed Dye LaserCombined Pulsed Dye Laser and Topical Ranibizumab for Treatment of Port Wine Stain Birthmarks
RanibizumabRanibizumabCombined Pulsed Dye Laser and Topical Ranibizumab for Treatment of Port Wine Stain Birthmarks
Primary Outcome Measures
NameTimeMethod
Port Wine Stain response to laser treatment8 weeks

Combined Pulsed Dye Laser and Topical Ranibizumab for Treatment of Port Wine Stain Birthmarks

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath